{
  "docId": "019de076-2049-75e8-9528-894c783c20b2",
  "docSlug": "1f0c6538bd85906c2fdac9c48c149895",
  "documentTitle": "argenx SE | Investor Presentation Deck | 25 slides",
  "authorId": "argenx-se",
  "authorName": "argenx",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 17,
  "pageCount": 25,
  "prevPage": 16,
  "nextPage": 18,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "balanced",
  "nDataPoints": 2,
  "notes": "Includes a biological mechanism diagram on the left and a clinical trial design timeline on the right.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de076-2049-75e8-9528-894c783c20b2/17",
  "deckHref": "/decks/019de076-2049-75e8-9528-894c783c20b2",
  "deckJsonHref": "/decks/019de076-2049-75e8-9528-894c783c20b2.json",
  "deckAnchorHref": "/decks/019de076-2049-75e8-9528-894c783c20b2#slide-17",
  "components": [
    {
      "bbox": {
        "h": 0.5,
        "w": 0.65,
        "x": 0.3,
        "y": 0.3
      },
      "kind": "diagram",
      "text": "First-in-Human Phase 1 Healthy Volunteer Study timeline with dose cohorts",
      "attrs": null,
      "subkind": "timeline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "260e42d4-53bb-4e93-81fd-2c15f84d0ad1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.28,
        "x": 0.02,
        "y": 0.3
      },
      "kind": "image",
      "text": "Biological mechanism diagram showing MuSK, LRP4, and AChR interaction",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8aa2dcc6-015f-4ac7-8b92-9d76a4bb691c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.5,
        "x": 0.25,
        "y": 0.8
      },
      "kind": "paragraph",
      "text": "First-in-patient trial in CMS to serve as proof of biology. Translational work ongoing in amyotrophic lateral sclerosis (ALS)",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "828569e5-423c-4360-9079-0ca8e2da054d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.45,
        "x": 0.03,
        "y": 0.05
      },
      "kind": "title",
      "text": "ARGX-119: MuSK Agonist with Broad Potential in Neuromuscular Disease",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1463f590-abad-4c81-959c-76a4348d5b87",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}